Led by SERAF and HDir, along with European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Norway joins the European Web Survey on Drugs this year.
News
A selection of articles in English about SERAF's research below. Read more about SERAF in the (Norwegian) media.
SERAF researchers Gabrielle Welle-Strand and Rebecca McDonald, in collaboration with Marianne Pierron, Ida Kristine Olsen, and Ronny Bjørnestad from proLAR Nett, have published a paper based on data from the 2021 proLAR Nett patient satisfaction survey.
Researcher Anne Bukten and Professor Thomas Clausen at SERAF along with colleague Marianne Riksheim Stavseth at OUS have just published their research in the journal The Lancet.
PriSUD project's recent results show that 60% of inmates in Norwegian prisons had at least one form of mental disorder during the 10-year observation period (2010-2019).
In a recently published article, SERAF researchers Rebecca McDonald, Desiree Eide, Svetlana Skurtveit and Thomas Clausen examined the opioid epidemic in North America as a man-made public health crisis.
Along with researchers at Sørlandet Hospital, SERAF has contributed to a new article on somatic symptoms among Norwegian patients in opioid maintenance treatment.
Researchers at the Oslo University Hospital and SERAF have interviewed individuals who had experienced a serious surgical trauma in the period after discharge from the hospital.
Registration is closed for ThINC-3 Naloxone conference in Oslo. Read more about conference here, or jump to the program.
In a recently published study by SERAF, in collaboration with the NIPH and KORFOR, researchers have examined fatal overdoses and associated factors among individuals who had been pharmacologically treated for chronic pain.
Among patients in opioid maintenance treatment (OMT), the use of additional high-risk prescription drugs can increase the risk of overdose. OMT patients in Norway frequently filled prescriptions for multiple high-risk drugs, and in higher doses than the general population.
People in OMT treatment who enter prison are a vulnerable group with complex challenges related to mental health. Despite the fact that they make up a significant and increasing proportion of the prison population, there is little knowledge about this vulnerable group.
Increased use of cocaine among younger adults in Norway has lately been the focus of many Norwegian media outlets.
The first findings from the evaluation of heroin-assisted treatment (HAT) indicate that patients perceive it to be a useful treatment.
As part of the POINT project, the article "Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?" has been published in BMC Primary Care. The article is a collaboration between researchers at SERAF UiO, NIPH, NTNU, St. Olav Hospital and RELIS.
New PriSUD article on mortality and incarceration in Health and Justice
POINT project researchers recently published a cohort description in Clinical Epidemiology detailing how chronic pain patients in Norway suffer from musculoskeletal pain.
Researchers at SERAF and Sørlandet Sykehus have published an article on smoking among people in substance abuse treatment (24-hour treatment and OMT).
The study builds on SERAF project NorComt.
SERAF researchers have contributed to a recently published article on mortality in opioid maintenance treatment (OMT) based on a long-term follow-up of OMT patients.
Together with researchers at Sørlandet Hospital and the University of Agder, SERAF has contributed to a new article that sheds light on attendance at and dropout from substance abuse treatment.
In a recently published article, SERAF researchers have shown that people who themselves use drugs and report previous experience of having witnessed overdoses are also the ones who most frequently use naloxone nasal spray as a life-saving measure in overdose situations.
A SERAF researcher contributed to a recent article about community-based low-threshold interventions for cannabis use disorder in Norway.
Together with international colleagues, researchers at SERAF have contributed to a recently published article on take-home naloxone distribution during the Covid-19 pandemic.
People who use drugs are compliant with the governmental recommendations on how to avoid Covid-19 infection.
A new study in a collaboration with researchers from Denmark, Finland, Iceland, Norway, and Sweden, investigates the use of opioids for pain with registers of filled prescriptions maintained in all five countries.
Professor Thomas Clausen has written a commentary in the journal Addiction on overdose prevention in light of the American opioid crisis.